Luke J. Dowman

Luke J. Dowman

Auto-generated profile, based on publicly available information

Luke J. Dowman

School of Chemistry and ARC Centre of Excellence for Innovations in Peptide and Protein Science The University of Sydney Sydney NSW 2006 Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2016 in Organic Letters
Verified
Journal Article
Closed access
AGAndrew M. Giltrap
Andrew M. Giltrap
LDLuke J. Dowman
Luke J. Dowman
GNGayathri Nagalingam
Gayathri Nagalingam
JOJessica L. Ochoa
Jessica L. Ochoa
RLRoger G. Linington
Roger G. Linington
RPRichard J. Payne
Richard J. Payne

24 May 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
TCTimothy S. Chisholm
Timothy S. Chisholm
DCDaniel Clayton
Daniel Clayton
LDLuke J. Dowman
Luke J. Dowman
JSJessica Sayers
Jessica Sayers
RPRichard J. Payne
Richard J. Payne

1 March 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAnh T. Tran
Anh T. Tran
EWEmma Elizabeth Watson
Emma Elizabeth Watson
VPVenugopal Pujari
Venugopal Pujari
TCTrent Conroy
Trent Conroy
LDLuke J. Dowman
Luke J. Dowman
RPRichard J. Payne
Richard J. Payne
Tuberculosis (TB) is responsible for enormous global morbidity and mortality, and current treatment regimens rely on the use of drugs that have been in use for more than 40 years. Owing to widespread resistance to these therapies, new drugs are desperately needed to control the TB disease burden. Herein, we describe the rapid synthesis of analogues of the sansanmycin uridylpeptide natural products that represent promising new TB drug leads. The compounds exhibit potent and selective inhibition of Mycobacterium tuberculosis, the etiological agent of TB, both in vitro and intracellularly. The natural product analogues are nanomolar inhibitors of Mtb phospho-MurNAc-pentapeptide translocase, the enzyme responsible for the synthesis of lipid I in mycobacteria. This work lays the foundation for the development of uridylpeptide natural product analogues as new TB drug candidates that operate through the inhibition of peptidoglycan biosynthesis.

3 February 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
CHCameron C. Hanna
Cameron C. Hanna
JKJulia Kriegesmann
Julia Kriegesmann
LDLuke J. Dowman
Luke J. Dowman
CBChristian Becker
Christian Becker
RPRichard James Payne
Richard James Payne
Lipidation is a ubiquitous modification of peptides and proteins that can occur either co‐ or post‐translationally. An array of different lipid classes can adorn proteins and has been shown to influence a number of crucial biological activities, including the regulation of signaling, cell–cell adhesion events, and the anchoring of proteins to lipid rafts and phospholipid membranes. Whereas nature employs a range of enzymes to install lipid modifications onto proteins, the use of these for the chemoenzymatic generation of lipidated proteins is often inefficient or impractical. An alternative is to harness the power of modern synthetic and semisynthetic technologies to access lipid‐modified proteins in a pure and homogeneously modified form. This Review aims to highlight significant advances in the development of lipidation and ligation chemistry and their implementation in the synthesis and semisynthesis of homogeneous lipidated proteins that have enabled the influence of these modifications on protein structure and function to be uncovered.

10 April 2015 in Organic Letters
Verified
Journal Article
Closed access
LMLara R. Malins
Lara R. Malins
AGAndrew M. Giltrap
Andrew M. Giltrap
LDLuke J. Dowman
Luke J. Dowman
RPRichard J. Payne
Richard J. Payne

20 December 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SAStijn M. Agten
Stijn M. Agten
EWEmma Elizabeth Watson
Emma Elizabeth Watson
JRJorge Ripoll‐Rozada
Jorge Ripoll‐Rozada
LDLuke J. Dowman
Luke J. Dowman
MWMike C. L. Wu
Mike C. L. Wu
RPRichard James Payne
Richard James Payne